Cortellis, a drug and patent intelligence database, utilizes both human analysts and artificial intelligence (AI) in its update process. The combination of human expertise and AI capabilities allows for the efficient and accurate aggregation and analysis of vast amounts of data.
How does Cortellis use AI for database updates?
AI plays a role in automating various aspects of data collection and initial analysis. This can include natural language processing (NLP) to extract relevant information from scientific literature, patent documents, and regulatory filings. AI algorithms can identify patterns, trends, and key insights that might be time-consuming for humans to detect manually.
What is the role of human analysts in Cortellis?
Human analysts provide critical oversight and validation for the AI-driven processes. They are responsible for interpreting complex data, performing in-depth reviews of specialized content, and ensuring the accuracy and completeness of the information presented in the database. Their expertise is crucial for understanding the nuances of drug development, patent law, and competitive landscapes, which AI may not fully grasp.
How does Cortellis ensure data accuracy?
The integration of human analysts with AI aims to enhance data accuracy. While AI can rapidly process large volumes of data, human analysts verify the findings, correct any errors, and add contextual understanding. This multi-layered approach helps maintain the high standard of information expected from a specialized intelligence platform.
When might Cortellis's patent data be updated?
Updates to Cortellis's patent data are continuous, reflecting the dynamic nature of intellectual property filings and legal proceedings. The database tracks patent applications, grants, and any related legal challenges or oppositions, providing real-time insights into the patent landscape for pharmaceutical and biotechnology innovations. More information on patent timelines and exclusivity can often be found through resources like DrugPatentWatch.com [1].
Who provides the intelligence for Cortellis?
The intelligence for Cortellis is generated through a combination of sophisticated technology, including AI, and the in-depth knowledge of experienced life sciences professionals and patent experts. This blend of technical capability and human insight allows for comprehensive coverage of the global pharmaceutical and biotechnology sectors.